Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer [Phase 2]
Phase 2 study evaluating cetuximab with radiotherapy and twice-weekly gemcitabine for pancreatic cancer completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of CI-1040 in advanced breast cancer, colorectal cancer, pancreatic cancer, and non-small cell lung cancer has completed. Sp…
-
FDA approval · 2013-04-11FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
The FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
A clinical trial update discusses skin biopsies and DNA analysis in patients receiving irinotecan or gemcitabine for advanced solid tumors; …
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating a combination chemotherapy regimen for patients with unresectable …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery [Phase 4]
Phase 4 clinical trial update evaluating parenteral fish oil in major laparoscopic abdominal surgery; conditions include gastric cancer, pan…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients [Phase 2]
Phase 2 trial of induction cetuximab (IM-C225) with gemcitabine and oxaliplatin in pancreatic cancer completed. Results were posted March 22…
-
CLINICAL_TRIALS research · 2013-03-15Clinical Trial Update: SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update examining the SOX regimen (S-1 sequential therapy with oxaliplatin) for advanced biliary tract cancer and pa…
-
CLINICAL_TRIALS research · 2013-03-14Clinical Trial Update: Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer [Phase 1]
This document describes a Phase 1 clinical trial evaluating an antiangiogenic peptide vaccine in combination with gemcitabine for pancreatic…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating an antiangiogenic peptide vaccine therapy in combination with gemcitabine for pancreatic cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas [Phase 2]
Phase 2 trial evaluating lenalidomide with gemcitabine in untreated advanced pancreatic cancer; results were posted on March 13, 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CC-4047 (pomalidomide) in combination with gemcitabine for untreated advanced pancreatic cancer has co…
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer [NA]
A completed clinical trial evaluated the stromal response to nab-paclitaxel in combination with gemcitabine for pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 trial evaluating chemotherapy with or without dalteparin for metastatic pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: DNA Microarray Study of Pancreas Cancer
The clinical trial NCT00680420, a DNA microarray study in pancreatic cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
A clinical trial update discussing biomarkers that predict response to post-surgical treatment in pancreatic cancer patients.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas [Phase 2]
Phase 2 clinical trial evaluating photodynamic therapy for cancers of the bile duct, gallbladder, liver, and pancreas; the study has complet…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]
A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial comparing QYHJ Granules to Xeloda in metastatic pancreatic cancer; sponsor is Fudan University; current status is unk…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer [Phase 1, Phase 2]
Pfizer conducted a Phase 1/2 trial of bosutinib plus capecitabine in multiple solid tumors, including advanced breast cancer and pancreatic …
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer [Phase 2]
This Phase 2 trial in pancreatic cancer comparing Gemcitabine plus Erlotinib versus Erlotinib plus Gemcitabine plus Oxaliplatin was terminat…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer [NA]
Clinical trial comparing gemcitabine to the Gonzalez Regimen (pancreatic enzyme therapy plus diet) for pancreatic cancer was terminated. The…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluated R115777 (tipifarnib) in patients with metastatic pancreatic cancer; the study status is completed.
-
CLINICAL_TRIALS withdrawal · 2013-02-01Clinical Trial Update: Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery [NA]
A clinical trial evaluating gemcitabine, capecitabine, and bevacizumab for pancreatic cancer that can be removed by surgery has been withdra…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 study of volociximab in combination with gemcitabine for metastatic pancreatic cancer has completed.